Clinical trials
Terminated Shock, Septic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 9 |
| 2014 | 2 |
| 2015 | 8 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 8 |
| 2019 | 9 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire Dijon | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva | 2 |
| The Cleveland Clinic | 2 |
| University of Athens | 2 |
| Wake Forest University Health Sciences | 2 |
| AdministrateurDRC | 1 |
| Alexander Flannery, 859-323-4011 | 1 |
| Alteco Medical AB | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Septic | 69 |
| Sepsis | 32 |
| Acute Kidney Injury | 6 |
| Shock | 6 |
| Critical Illness | 4 |
| Infections | 3 |
| Multiple Organ Failure | 3 |
| Systemic Inflammatory Response Syndrome | 3 |
| Edema | 2 |
| Hypotension | 2 |
Trials
Showing 76 to 69 of 69. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.